India's focus on APIs and generics helped growth in 2009

Related tags Pharmacology Pharmaceutical drug

The Indian pharmaceutical market was worth $10.8bn (€7.5bn) this year and will more than double in value by 2014 according to a new industry report by Cygnus Business Consulting & Research.

The authors of the “Indian Pharmaceutical Market” report argue that the 13 per cent expansion seen in India over the last 12 months is evidence that the industry was relatively unaffected by the global downturn.

They ascribe this performance to both strong internal demand and the sector’s continued focus on active pharmaceutical ingredient (API) and generics production.

The Cygnus analysts go on suggest that, going forward, growth will be driven by increasing investment in R&D, an increase in the number of ANDAs and DMFs, greater M&A activity and in-licensing.

They also predict that India’s thriving custom research and manufacturing sector (CRAMS), as exemplified by players like Jubilant Organosys, will give an “edge to Indian pharma companies in the coming years​.”

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us